Dr. James Robinson, MD

• Pediatric Infectious Disease Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Yale University School Of Medicine 1974

  Fellowship Hospital

• University Of Vermont Medical Center 1973

  Residency Hospital

• Tulane University School Of Medicine

  Medical School

• Correction: Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report, 2011-10-25

• SARS-CoV-2 Epitopes following Infection and Vaccination Overlap Known Neutralizing Antibody Sites, 2022-07-09

• Lassa hemorrhagic fever in a late term pregnancy from northern sierra leone with a positive maternal outcome: case report, 2011-08-15

• Escape from Autologous Neutralizing Antibodies in Acute/Early Subtype C HIV-1 Infection Requires Multiple Pathways, 2009-09-18

• Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans, 2021-11-21

• Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies, 2016-08-13

• Convergent structures illuminate features for germline antibody binding and pan-Lassa virus neutralization, 2019-08-08

• NovelPneumocystisAntigens for Seroprevalence Studies, 2023-05-24

• Epitopes for Broad and Potent Neutralizing Antibody Responses during Chronic Infection with Human Immunodeficiency Virus Type 1, 2009-11-17

• Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail, 2021-06-23

• Conformational instability governed by disulfide bonds partitions the dominant from subdominant helper T-cell responses specific for HIV-1 envelope glycoprotein gp120, 2015-05-02

• A cocktail of protective antibodies subverts the dense glycan shield of Lassa virus, 2022-10-26

• Neutralizing activity of antibodies to the V3 loop region of HIV-1 gp120 relative to their epitope fine specificity, 2008-09-26

• Shaping T Cell - B Cell Collaboration in the Response to Human Immunodeficiency Virus Type 1 Envelope Glycoprotein gp120 by Peptide Priming, 2013-06-11

• Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth, 2013-02-28

• Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient, 2010-02-04

• Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV, 2016-04-25

• Multi-Parameter Exploration of HIV-1 Virus-Like Particles as Neutralizing Antibody Immunogens in Guinea Pigs, Rabbits and Macaques, 2014-05-03

• ACE2-IgG1 fusions with improvedin vitroandin vivoactivity against SARS-CoV-2, 2021-12-20

• Structural basis for antibody-mediated neutralization of Lassa virus, 2017-06-02

• Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits, 2016-05-10

• Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site, 2015-05-29

• Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever, 2017-09-04

• Lassa Fever in Post-Conflict Sierra Leone, 2014-03-20

• Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies, 2022-05-24